Nucl Med Mol Imaging.
2013 Jun;47(2):146-147.
18F-FDG PET/CT Presentation in a Patient Diagnosed with Large Cell Neuroendocrine Carcinoma of Uncertain Primary
- Affiliations
-
- 1Department of Nuclear Medicine, Fondazione Poliambulanza, Brescia, Italy. fedefournier@libero.it
- 2Department of Pathological Anatomy, Fondazione Poliambulanza, Brescia, Italy.
- 3Division of Geriatrics, Fondazione Poliambulanza, Brescia, Italy.
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Use of 18F-FDG PET/CT in Second Primary Cancer
- F18-fluorodeoxyglucose-positron emission tomography and computed tomography is not accurate in preoperative staging of gastric cancer
- Late Port Site Metastasis from Occult Gall Bladder Carcinoma After Laparoscopic Cholecystectomy for Cholelithiasis: The Role of 18F-FDG PET/CT
- Opportunities for 2-[18F] Fluoro-2-Deoxy-D-Glucose PET/CT in Cervical-Vaginal Neuroendocrine Carcinoma: Case Series and Literature Review
- Esophageal Leiomyoma with intense FDG uptake on 18F-FDG PET/CT
